 James Orth
Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle | 7 | 2018 | 546 | 1.680 |
Why?
| | Karyopherins | 2 | 2018 | 17 | 1.230 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2018 | 196 | 1.090 |
Why?
| | Cell Tracking | 2 | 2016 | 13 | 1.080 |
Why?
| | Mitosis | 6 | 2011 | 172 | 1.000 |
Why?
| | Hydrazines | 3 | 2018 | 28 | 0.830 |
Why?
| | DNA Damage | 2 | 2017 | 356 | 0.830 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2018 | 450 | 0.790 |
Why?
| | Triazoles | 3 | 2018 | 126 | 0.760 |
Why?
| | Antineoplastic Agents | 7 | 2018 | 1941 | 0.700 |
Why?
| | Cell Cycle Checkpoints | 3 | 2018 | 85 | 0.680 |
Why?
| | Apoptosis | 5 | 2018 | 2433 | 0.610 |
Why?
| | Antimitotic Agents | 4 | 2011 | 8 | 0.600 |
Why?
| | Single-Cell Analysis | 3 | 2016 | 189 | 0.580 |
Why?
| | Endocytosis | 3 | 2006 | 150 | 0.570 |
Why?
| | Time-Lapse Imaging | 1 | 2016 | 19 | 0.550 |
Why?
| | Tubulin Modulators | 3 | 2014 | 10 | 0.540 |
Why?
| | Cell Line, Tumor | 9 | 2020 | 2814 | 0.490 |
Why?
| | Cell Death | 4 | 2017 | 333 | 0.450 |
Why?
| | Paclitaxel | 4 | 2011 | 192 | 0.420 |
Why?
| | Dynamins | 5 | 2006 | 30 | 0.410 |
Why?
| | Neoplasms | 9 | 2020 | 2147 | 0.400 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2020 | 730 | 0.390 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2022 | 139 | 0.360 |
Why?
| | Microscopy | 3 | 2016 | 125 | 0.330 |
Why?
| | Actins | 5 | 2005 | 386 | 0.300 |
Why?
| | Cell Surface Extensions | 3 | 2004 | 11 | 0.300 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2022 | 346 | 0.290 |
Why?
| | Cell Survival | 4 | 2018 | 1030 | 0.270 |
Why?
| | ErbB Receptors | 2 | 2006 | 569 | 0.270 |
Why?
| | Phenotype | 2 | 2015 | 2891 | 0.260 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2006 | 229 | 0.250 |
Why?
| | Eukaryotic Cells | 1 | 2003 | 34 | 0.220 |
Why?
| | Microfilament Proteins | 4 | 2005 | 129 | 0.210 |
Why?
| | Actin Cytoskeleton | 1 | 2003 | 99 | 0.210 |
Why?
| | Molecular Chaperones | 2 | 2022 | 161 | 0.200 |
Why?
| | GTP Phosphohydrolases | 1 | 2002 | 68 | 0.200 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2020 | 668 | 0.190 |
Why?
| | Spindle Apparatus | 3 | 2010 | 86 | 0.190 |
Why?
| | Benzoxazoles | 1 | 2020 | 16 | 0.180 |
Why?
| | Azepines | 1 | 2020 | 67 | 0.180 |
Why?
| | Microscopy, Fluorescence | 5 | 2014 | 404 | 0.180 |
Why?
| | Proteolysis | 1 | 2019 | 147 | 0.160 |
Why?
| | Cell Movement | 2 | 2003 | 877 | 0.160 |
Why?
| | G1 Phase | 1 | 2018 | 68 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 56 | 0.160 |
Why?
| | Imidazoles | 1 | 2018 | 214 | 0.150 |
Why?
| | Pyrimidines | 1 | 2020 | 379 | 0.150 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2017 | 1889 | 0.150 |
Why?
| | Cell Lineage | 1 | 2018 | 314 | 0.140 |
Why?
| | Humans | 20 | 2020 | 117053 | 0.140 |
Why?
| | HeLa Cells | 5 | 2011 | 577 | 0.140 |
Why?
| | Piperazines | 1 | 2018 | 314 | 0.130 |
Why?
| | DNA Replication | 1 | 2017 | 210 | 0.130 |
Why?
| | Dynamin II | 2 | 2005 | 4 | 0.130 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2015 | 111 | 0.130 |
Why?
| | Saccharomyces cerevisiae | 1 | 2019 | 491 | 0.130 |
Why?
| | Benzopyrans | 1 | 2014 | 25 | 0.120 |
Why?
| | Animals | 15 | 2020 | 32737 | 0.120 |
Why?
| | Furans | 1 | 2014 | 23 | 0.120 |
Why?
| | Isoquinolines | 1 | 2014 | 38 | 0.120 |
Why?
| | Tetrazoles | 1 | 2014 | 32 | 0.120 |
Why?
| | Ketones | 1 | 2014 | 46 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 803 | 0.120 |
Why?
| | Neoplasms, Experimental | 1 | 2015 | 156 | 0.120 |
Why?
| | Cortactin | 4 | 2006 | 7 | 0.120 |
Why?
| | Quinolines | 2 | 2011 | 128 | 0.120 |
Why?
| | RNA Interference | 3 | 2011 | 452 | 0.120 |
Why?
| | Fluorescent Dyes | 1 | 2015 | 305 | 0.110 |
Why?
| | Mice, Nude | 2 | 2014 | 653 | 0.110 |
Why?
| | Protein Binding | 2 | 2017 | 1949 | 0.110 |
Why?
| | Mice | 8 | 2020 | 15309 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1374 | 0.100 |
Why?
| | Deoxyribonucleases | 1 | 2011 | 21 | 0.100 |
Why?
| | Holoenzymes | 2 | 2022 | 21 | 0.090 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 775 | 0.090 |
Why?
| | RNA, Small Interfering | 2 | 2010 | 561 | 0.090 |
Why?
| | Protein Structure, Tertiary | 2 | 2003 | 818 | 0.090 |
Why?
| | Transfection | 3 | 2014 | 877 | 0.090 |
Why?
| | Fibroblasts | 2 | 2006 | 839 | 0.080 |
Why?
| | Amino Acid Sequence | 4 | 2006 | 2032 | 0.080 |
Why?
| | Cell Cycle Proteins | 2 | 2010 | 563 | 0.080 |
Why?
| | Chromosome Segregation | 1 | 2008 | 35 | 0.080 |
Why?
| | Molecular Sequence Data | 4 | 2006 | 2817 | 0.080 |
Why?
| | Cell Membrane | 3 | 2006 | 681 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 3 | 2014 | 646 | 0.080 |
Why?
| | Genetic Therapy | 1 | 2009 | 266 | 0.080 |
Why?
| | Cell Line | 6 | 2014 | 2670 | 0.080 |
Why?
| | Genome, Human | 1 | 2009 | 377 | 0.070 |
Why?
| | Adenosine Triphosphatases | 2 | 2022 | 157 | 0.070 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 218 | 0.070 |
Why?
| | COS Cells | 1 | 2006 | 179 | 0.070 |
Why?
| | Microtubules | 1 | 2008 | 239 | 0.070 |
Why?
| | Epidermal Growth Factor | 1 | 2006 | 168 | 0.070 |
Why?
| | Caveolins | 1 | 2005 | 6 | 0.070 |
Why?
| | ADP-Ribosylation Factor 1 | 1 | 2005 | 4 | 0.060 |
Why?
| | Green Fluorescent Proteins | 2 | 2009 | 390 | 0.060 |
Why?
| | Golgi Apparatus | 1 | 2005 | 91 | 0.060 |
Why?
| | Cryptosporidium parvum | 1 | 2004 | 13 | 0.060 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2004 | 24 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2006 | 332 | 0.060 |
Why?
| | Coated Pits, Cell-Membrane | 1 | 2003 | 4 | 0.060 |
Why?
| | Cell Size | 1 | 2003 | 80 | 0.050 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2003 | 81 | 0.050 |
Why?
| | Rats | 4 | 2005 | 5172 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 145 | 0.050 |
Why?
| | Microscopy, Video | 1 | 2002 | 26 | 0.050 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2002 | 40 | 0.050 |
Why?
| | Models, Biological | 3 | 2009 | 1689 | 0.050 |
Why?
| | Phosphorylation | 1 | 2006 | 1590 | 0.050 |
Why?
| | Proline | 1 | 2002 | 70 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2008 | 2236 | 0.050 |
Why?
| | Plasmids | 1 | 2002 | 352 | 0.050 |
Why?
| | Luminescent Proteins | 1 | 2002 | 173 | 0.050 |
Why?
| | Hepatocytes | 1 | 2002 | 204 | 0.050 |
Why?
| | Cdc20 Proteins | 2 | 2010 | 4 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2004 | 540 | 0.050 |
Why?
| | Aurora Kinase A | 1 | 2020 | 51 | 0.040 |
Why?
| | Time Factors | 3 | 2009 | 6240 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 59 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 436 | 0.040 |
Why?
| | Maximum Tolerated Dose | 1 | 2020 | 183 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 103 | 0.040 |
Why?
| | Pancreatic Neoplasms | 1 | 2006 | 716 | 0.040 |
Why?
| | Mutation | 3 | 2009 | 3420 | 0.040 |
Why?
| | Microscopy, Confocal | 2 | 2014 | 308 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2015 | 696 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1657 | 0.040 |
Why?
| | Models, Molecular | 1 | 2022 | 1405 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2015 | 1159 | 0.030 |
Why?
| | Signal Transduction | 2 | 2006 | 4606 | 0.030 |
Why?
| | Microscopy, Immunoelectron | 2 | 2005 | 45 | 0.030 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2014 | 99 | 0.030 |
Why?
| | Microinjections | 2 | 2005 | 78 | 0.030 |
Why?
| | Drug Carriers | 1 | 2014 | 115 | 0.030 |
Why?
| | Macromolecular Substances | 2 | 2005 | 201 | 0.030 |
Why?
| | Cytoskeleton | 2 | 2003 | 177 | 0.030 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 10 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2011 | 28 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2011 | 38 | 0.020 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2011 | 55 | 0.020 |
Why?
| | Nanoparticles | 1 | 2014 | 320 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 188 | 0.020 |
Why?
| | Cyclin B1 | 1 | 2009 | 5 | 0.020 |
Why?
| | Nocodazole | 1 | 2009 | 17 | 0.020 |
Why?
| | Cyclin B | 1 | 2009 | 14 | 0.020 |
Why?
| | Transcriptome | 1 | 2015 | 756 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2009 | 34 | 0.020 |
Why?
| | Permeability | 1 | 2009 | 153 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 216 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1172 | 0.020 |
Why?
| | HT29 Cells | 1 | 2008 | 37 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2008 | 69 | 0.020 |
Why?
| | Epithelial Cells | 2 | 2004 | 940 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2011 | 615 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2009 | 408 | 0.020 |
Why?
| | Caspases | 1 | 2008 | 259 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 860 | 0.020 |
Why?
| | Models, Statistical | 1 | 2009 | 627 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 51 | 0.020 |
Why?
| | Caveolin 1 | 1 | 2005 | 23 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 303 | 0.020 |
Why?
| | Peptide Mapping | 1 | 2005 | 61 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2011 | 1040 | 0.020 |
Why?
| | Wiskott-Aldrich Syndrome | 1 | 2004 | 3 | 0.020 |
Why?
| | Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2004 | 2 | 0.020 |
Why?
| | Osteoclasts | 1 | 2004 | 36 | 0.020 |
Why?
| | Pseudopodia | 1 | 2004 | 20 | 0.020 |
Why?
| | Cryptosporidiosis | 1 | 2004 | 14 | 0.020 |
Why?
| | Biliary Tract Diseases | 1 | 2004 | 34 | 0.010 |
Why?
| | rho GTP-Binding Proteins | 1 | 2004 | 64 | 0.010 |
Why?
| | Protein Transport | 1 | 2005 | 402 | 0.010 |
Why?
| | Actin-Related Protein 3 | 1 | 2003 | 1 | 0.010 |
Why?
| | Clathrin | 1 | 2003 | 24 | 0.010 |
Why?
| | Transferrin | 1 | 2003 | 39 | 0.010 |
Why?
| | src Homology Domains | 1 | 2003 | 33 | 0.010 |
Why?
| | Host-Parasite Interactions | 1 | 2004 | 110 | 0.010 |
Why?
| | Endoplasmic Reticulum | 1 | 2005 | 240 | 0.010 |
Why?
| | Dextrans | 1 | 2003 | 74 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 263 | 0.010 |
Why?
| | Lipoproteins, LDL | 1 | 2003 | 131 | 0.010 |
Why?
| | Aged | 1 | 2020 | 19359 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2003 | 516 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1588 | 0.010 |
Why?
| | Female | 2 | 2020 | 60635 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 27173 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2005 | 3956 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1271 | 0.010 |
Why?
| | Liver | 1 | 2003 | 1744 | 0.010 |
Why?
| | Male | 1 | 2020 | 56665 | 0.010 |
Why?
|
|
Orth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|